Road to Recovery: Stock Hotlist for The Week of June 15th, 2020

Second Wave: The Top 3 Coronavirus Stocks That Could Run Again 

Here we go again.

Just weeks after global economies reopened, “second wave” coronavirus fears could send us all back indoors.  Several California counties reported an increase in cases.

Florida just saw a surge of 8,533 new cases reported.



We’re just beginning to see an explosion of cases in Alaska, Arkansas, Kentucky, Mississippi, North Carolina, Oregon, South Carolina, and Utah.  Phoenix Mayor Kate Gallego even just admitted, “We opened too much too early and so our hospitals are really struggling.”

If we see even more cases, it could force the economy to close up shop again.  And if that’s the case, coronavirus stocks could be thrust back into the spotlight.

Coronavirus Stock No. 1 – Alpha Pro Tech (APT)

If we see a resurgence of the coronavirus, demand for face masks could explode higher yet again.  The first time we saw explosive demand, APT exploded from a low of $5 to a high of $41.59.  While the stock has pulled back to $13.50, we could see another spike if the coronavirus threat makes another go at the global population.

Coronavirus Stock No. 2 – Teladoc Health (TDOC)

Of course, we could see even more demand for telehealth services.

All with hospitals, federal, and state governments around the world supporting telehealth programs to cut back on in-person meetings in in-patient and out-patient care settings.  Also, according to McKinsey & Co., 76% of consumers say they were now moderately or highly interested in using telehealth, as compared to 11% in 2019.  

Coronavirus Stock No. 3 – Moderna Inc. (MRNA)

According to Bloomberg, Moderna vaccine trials are moving fast with a final study set for July 2020.  “The final study, which will include 30,000 people, will be conducted in collaboration with the National Institute of Allergy and Infectious Diseases in the U.S. Its primary goal will be to show the vaccine prevents people from developing symptoms of Covid-19.” 



NEXT: